Back to Trades
Cole Ryan
Chief Operating OfficerCIK 0002126966
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 1
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2026
Cole Ryan, Chief Operating Officer, has filed 1 SEC report (2026), all concentrated in Aurinia Pharmaceuticals Inc. (AUPH), totaling $1.1M in disclosed volume. Data is sourced from official SEC Form 3, 4, and 5 filings.